Goodrx shares are rising after reaching a Novo Nordisk GLP-1 deal for $ 499 per month
Goodrx (GDRX) joins the action of GLP-1 with a message on Monday that it will start selling as Novo Nordisk’s GLP-1 medicines (NVO), Ozmpic for diabetes and Wegovy for weight loss at $ 499 per month. The partnership comes as the telephone and digital health platforms are increasingly regarded as ways to provide more access … Read more